Votre Partenaire en Modélisation & Simulation Pharmacocinétique !

PhInc. Modeling met en place la meilleure stratégie de Modélisation & Simulation pour orienter les étapes clefs de votre développement et optimiser ses coûts.
Les services PhInc. Modeling
Nos actualités

Ils nous font confiance

Sakina Sayah-Jeanne
Sakina Sayah-Jeanne
Senior Director, Translational R&D - Da Volterra
PhinC has been accompanying Da Volterra for several years on PBPK Modelling activities. Our collaboration, based on mutual trust, has already been very fruitful and has allowed Da Volterra to gain precious knowledge on its product under development. Da Volterra enjoys working with PhinC and will continue to do so in the years to come, leaning from its expertise.
John DiBella
John DiBella
President, Lancaster Division - Simulations Plus, Inc. (NASDAQ: SLP)
Simulations Plus has formed a strong relationship with PhinC as we work together to drive increased adoption of physiologically-based pharmacokinetic (PBPK) modeling to support pharmaceutical research and development. Their talented team of scientists have become proficient users of our GastroPlus™ software platform, and we are confident that the services they provide to clients are valuable and greatly impact R&D productivity.
Antoine Tarral
Antoine Tarral
Head of HAT Clinical Programme - DNDi
The PhinC Development team has accompanied us throughout this program. In particular, their expertise in pharmacokinetic modeling has enabled us to select the therapeutic dose and optimize the dose regimen. I most particularly appreciated their continuous involvement, their professionalism and their ability to work together with all the other actors involved in this program.
BioQuébec
Montreal International
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
AFPT